Nonetheless, recent evidence from a mouse model of melanoma demonstrated that TRM cell activation can trigger the maturation and migration of dermal DCs to LNs, and induce new cytotoxic CD8+ T cell responses that suppress the growth of the primary tumor and of melanoma cells disseminated to the lung [15]. This evidence concerns the gene CD8A and neoplasm.